Sergio Schwartzman, M.D.
Sergio Schwartzman, MD, is the Franchellie M. Cadwell Associate Professor of Clinical Medicine at Cornell Weill Medical College, and Associate Attending Physician at the New York Presbyterian Hospital and at the Hospital for Special Surgery in New York City.
Dr. Schwartzman earned his medical degree at Mount Sinai School of Medicine in New York City.
internship and residency in internal medicine at Long Island Jewish Hillside Medical Center
in New Hyde Park, New York.
fellowship was conducted in the Department of Rheumatic Diseases at the New York Hospital
and the Hospital for Special Surgery.
has authored or coauthored over 50 articles, abstracts, books, and book chapters concerning rheumatoid arthritis, lupus, autoimmune ophthalmic disease, and related topics.
He is a member of the American College of Rheumatology, the Association for Research in Vision and Ophthalmology, the Spondyloarthritis Research and Treatment Network, the American Uveitis Society and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
is the recipient of numerous honors and awards, including the Fellows Award
presented by the Northeast Regional American Rheumatism Association
and The Franchellie M. Cadwell Chair.
He has served as an Ad Hoc Journal Reviewer for: Arthritis & Rheumatism, Emerging Infectious Diseases, Journal of Rheumatology, The Musculoskeletal Journal of Hospital for Special Surgery, Seminars in Arthritis and Rheumatism, Arthritis Research & Therapy, Medscape Rheumatology Editorial Advisory, Board Arthritis Care and Research, WebMD Rheumatology editorial board Up to Date.
Additionally, he was a member of the following ACR committees: 2010 ACR Abstract Selection Committee Spondylarthropathies and Psoriatic Arthritis2012 ACR Abstract Selection Committee Rheumatoid Arthritis.
has lectured frequently at the ACR Meet the Professor Sessions on difficult to treat RA, and autoimmune ophthalmic diseases.
current research interests include the development and implementation of an institutionally based objective outcome research registry for the inflammatory arthritides (Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis) and defining and treating autoimmune diseases of the eye, including uveitis, vasculitis, scleritis, and autoimmune orbital inflammatory disease.
is also involved in therapeutic studies defining the role of new agents in the treatment of all autoimmune diseases.